Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00427557 · OUTCOME

Number of Participants With Engraftment

Cellular Therapy With Cord Blood Cells · Source last updated 2012-05-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Baseline to 100 days post-engraftment

What was measured

Engraftment defined as first of three (3) consecutive days with Absolute neutrophil count (ANC) equal to or more than 0.5 \* 10\^9/L; assessed from baseline to 100 days post-engraftment.

Analysis population: Analysis per protocol.

Groups in this outcome

Fludarabine + Melphalan + Umbilical Cord Blood Unit

Fludarabine 30 mg/m\^2 given daily for four days. Melphalan 140 mg/m\^2 given for one day. Umbilical Cord Blood Unit given on one day.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Fludarabine + Melphalan + Umbilical Cord Blood Unit30

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Fludarabine + Melphalan + Umbilical Cord Blood Unit27Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        27
denoms
  1. counts
    1. group Id
      OG000
      value
      30
    units
    Participants
description
Engraftment defined as first of three (3) consecutive days with Absolute neutrophil count (ANC) equal to or more than 0.5 \* 10\^9/L; assessed from baseline to 100 days post-engraftment.
groups
  1. description
    Fludarabine 30 mg/m\^2 given daily for four days. Melphalan 140 mg/m\^2 given for one day. Umbilical Cord Blood Unit given on one day.
    id
    OG000
    title
    Fludarabine + Melphalan + Umbilical Cord Blood Unit
param Type
NUMBER
population Description
Analysis per protocol.
reporting Status
POSTED
time Frame
Baseline to 100 days post-engraftment
title
Number of Participants With Engraftment
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice